US Patent Issued to Jiangsu Hengrui Medicine, SHANGHAI HENGRUI PHARMACEUTICAL on Sept. 22 for "Pharmaceutical composition containing antibody against IL-5 and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,004, issued on Sept. 22, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang, China) and SHANGHAI HENGRUI PHARMACEUTICAL Co. LTD. (Shanghai).

"Pharmaceutical composition containing antibody against IL-5 and use thereof" was invented by Tingting Wu (Shanghai), Hao Li (Shanghai), Xun Liu (Shanghai) and Weikang Tao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed in the present application are a pharmaceutical composition containing an antibody against IL-5 and use thereof. In particular, disclosed in the present application is a pharmaceutical composition, which contains an IL-5 antibody or an antigen binding fragment the...